Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction

Journal of the American College of Cardiology

Volumn 30, Issue 5, 1997, Pages 1193-1199

  Taniyama, Yoshiaki ^a   Ito, Hiroshi ^a   Iwakura, Katsuomi ^a   Masuyama, Tohru ^b   Hori, Masatsugu ^b   Takiuchi, Shin ^a   Nishikawa, Nagahiro ^a   Higashino, Yorihiko ^a   Fujii, Kenshi ^a   Minamino, Takazo ^a  

^a Sakurabashi Watanabe Hospital   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VERAPAMIL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART VENTRICLE WALL MOTION; HUMAN; INTRACORONARY INFUSION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY VESSELS; ECHOCARDIOGRAPHY; FEMALE; HEART; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REGIONAL BLOOD FLOW; TREATMENT OUTCOME; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT; VERAPAMIL;

EID: 0030729434     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00277-5     Document Type: Article

References (29)

1. Bates ER, Krell MJ, Dean EN, O'Neill WW, Vogel RA. Demonstration of "no reflow" phenomenon by digital coronary arteriography. Am J Cardiol. 57:1986;177-178.
2. Jeremy RW, Links JM, Becker CC. Progressive failure of coronary flow during reperfusion of myocardial infarction documentation of the no reflow phenomenon with positron emission tomography . J Am Coll Cardiol. 16:1990;695-704.
3. Feld H, Lichstein E, Schachter J, Shani J. Early and late angiographic findings of the "no reflow" phenomenon following direct angioplasty as primary treatment for acute myocardial infarction. Am Heart J. 123:1992;782-784.
4. Ito H, Tomooka T, Sakai N, Yu H, et al. Lack of myocardial perfusion immediately after successful thrombolysis a predictor of poor recovery of left ventricular function in anterior myocardial infarction . Circulation. 85:1992;1699-1705.
5. Ito H, Iwakura K, Oh H, et al. Temporal changes in myocardial perfusion patterns in patients with reperfused anterior wall myocardial infarction their relation to myocardial viability . Circulation. 91:1995;656-662.
6. Ito H, Okamura A, Iwakura K, et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation. 93:1996;1993-1999.
7. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of 'no reflow' phenomenon a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction . Circulation. 93:1996;223-228.
8. Stahl LD, Aversano TR, Becker LC. Selective enhancement of function of stunned myocardium by increased flow. Circulation. 74:1986;843-851.
9. Babbitt DG, Virmani R, Forman MB. Intracoronary adenosine administrated after reperfusion limits vascular injury after prolonged ischemia in the canine model. Circulation. 80:1989;1388-1399.
10. Piana RN, Paik GY, Mosucci M, et al. Incidence and treatment of "no reflow" after percutaneous coronary intervention. Circulation. 89:1994;2514-2518.
11. Ragosta M, Camarano G, Kaul S, Poweas ER, Sarembock IJ, Gimple LW. Microvascular integrity indicates myocellular viability in patients with recentmyocardial infarction. Circulation. 89:1994;2562-2569.
12. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I a comparison between intravenous plasminogen activator and intravenous streptokinase . Clinical findings through hospital discharge. Circulation. 76:1987;142-154.
13. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count a quantitative method of assessing coronary artery flow . Circulation. 93:1996;879-888.
14. Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects a prospective study . Circulation. 74:1986;469-476.
15. Pomerantz R, Kuntz RE, Diver DJ, Safian RD, Baim DS. Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm following PTCA. Cathet Cardiovasc Diagn. 24:1991;283-285.
16. Feld H, Lichstein E, Schachter J, Shani J. Early and late angiographic findings of the "no reflow" phenomenon following direct angioplasty as primary treatment for acute myocardial infarction. Am Heart J. 123:1992;782-785.
17. Kloner RA, Ganote CE, Jennings RB. The "no reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 54:1974;1496-1508.
18. Kloner RA, Rude RE, Carlson N, Maroko PR, DeBoer LWV, Braunwald E. Ultrastructural evidence of microvasular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation. 62:1980;945-952.
19. Kloner RA, Ellis SG, Lange R, Braunwald E. Studies of experimental coronary artery reperfusion effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular change . Circulation. 68:(Suppl I):1983;I-18-5.
20. Johnson WB, Malone SA, Pantely GA, Anselone CG, Bristow JD. No reflow and extent of infarction during maximal vasodilation in the porcine heart. Circulation. 78:1988;462-472.
21. Campbell CA, Kloner RA, Alker K, Braunwald E. Effect of verapamil on infarct size in dogs subjected to coronary artery occlusion with transient reperfusion. J Am Coll Cardiol. 8:1986;1169-1174.
22. Wilson RF, Laxon DD, Lesser JR, White CW. Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions. Lancet. 1:1989;807-811.
23. Kloner RA, Prynzklenk K. Experimental infarct size reduction with calcium channel blockers. J Am Coll Cardiol. 18:1991;876-878.
24. Antman EM, Stone PH, Muller JE, Braunwald E. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I Basic and clonical electrophysiologic effects. Ann Intern Med . 93:1980;875-885.
25. Stone PH, Antman EM, Muller JE, Braunwald E. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II Hemodynamic effects and clinical applications. Ann Intern Med . 93:1980;886-904.
26. Kloner RA, Braunwald E. Observations on experimental myocardial ischemia. Cardiovasc Res. 14:1980;371-395.
27. Ikeda Y, Kikuchi M, Watanabe K, Ando Y. Inhibition of human platelet functions by verapamil. Thromb Haemost. 45:1981;158-161.
28. Campbell CA, Kloner RA, Alker KJ, Braunwald E. Effect of verapamil on infarct size in dogs subjected to coronary artery occlusion with transient reperfusion. J Am Coll Cardiol. 8:1986;1169-1174.
29. Higginson L, Tang A, Knoll G, Calvin J. Effect of intracoronary diltiazem on infarct size and regional myocardial function in the ischemic reperfused canine heart. J Am Coll Cardiol. 18:1991;868-875.